Cancer Immunotherapy: Targeting Tumors with Light and Antibodies
A cancer treatment called photoimmunotherapy involves injecting patients with an agent, then exposing their tumors to near infrared light. It was developed by a Japanese researcher who works at the US National Institutes of Health. Japan became the first country to use it on a patient in 2021. The agent that's injected contains cancer-specific antibodies, to which special chemicals are attached. After the antibodies bind to cancer, near infrared light is applied, killing the cancer cells.
This Japanese researcher developed photoimmunotherapy
This oral cancer patient received photoimmunotherapy
The agent reacts by killing only the cancer cells
Loosen stiff muscles with stretches that are based on karate